Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2014
07/30/2014CN103951751A 一种a型单端孢霉烯族毒素多克隆抗体及其制备方法与应用 One kind of a single-family trichothecene toxin polyclonal antibody preparation method and application
07/30/2014CN103951750A 抗喹乙醇和安普霉素的双特异性单克隆抗体及其制备方法 Apramycin anti olaquindox and bispecific monoclonal antibodies and methods
07/30/2014CN103951749A 一种抗金黄色葡萄球菌eLtaS蛋白的单克隆中和性抗体E4-2的制备及其应用 Preparation and application of an anti-Staphylococcus aureus eLtaS protein monoclonal neutralizing antibodies E4-2's
07/30/2014CN103951748A 一种抗金黄色葡萄球菌eLtaS蛋白的单克隆中和性抗体E4-1的制备及其应用 Preparation and application of an anti-Staphylococcus aureus eLtaS protein monoclonal neutralizing antibodies E4-1's
07/30/2014CN103951747A 1-氨基-2-萘酚作为半抗原的应用及相应的人工抗原、抗体 1-amino-2-naphthol as a hapten application and the corresponding artificial antigens, antibodies
07/30/2014CN103951577A 一种辣椒素人工半抗原、人工抗原及其制备方法 An artificial hapten, artificial antigen and its preparation method capsaicin
07/30/2014CN103102415B 一种同时检测吡虫啉和甲基对硫磷的双特异单克隆抗体 To simultaneously detect imidacloprid and methyl parathion bispecific monoclonal antibody
07/30/2014CN103059135B 蜂王浆主蛋白MRJP1特异性抗体及其制备方法与Elisa定量检测 Royal jelly MRJP1 main protein-specific antibodies and preparation method and quantitative detection Elisa
07/30/2014CN103025761B 人源化抗白介素3受体α链抗体 Humanized anti-interleukin-3 receptor α chain antibody
07/30/2014CN102838675B Ip-10抗体及其用途 Ip-10 antibodies and uses thereof
07/30/2014CN102702345B 一种三聚氰胺抗原、相关抗体及其制备方法 An antigen, antibodies and methods related to the melamine
07/30/2014CN102597001B 在ffpe材料中用于检测整联蛋白复合体的抗体 Integrin antibody used to detect protein complexes in ffpe material
07/30/2014CN102590515B 艰难梭菌外毒素a检测试剂盒及组成该试剂盒的单克隆抗体 Detection of Clostridium difficile toxin a kit and the kit composed of monoclonal antibodies
07/30/2014CN102373215B 具有增加的Fc受体结合亲和性和效应子功能的CD20抗体 Having increased Fc receptor binding affinity and effector function CD20 antibody
07/30/2014CN102326075B 纤维素类凝胶、填充剂及填充剂的制法、免疫球蛋白制剂的制法 Cellulose-based gel filler, and the filler preparation method, the immunoglobulin formulation is prepared by
07/30/2014CN102286100B 一种抗金黄色葡萄球菌肠毒素B的免疫球蛋白F(ab')<sub>2</sub>及其制备方法 An anti-Staphylococcus aureus enterotoxin B immunoglobulin F (ab ') <sub> 2 </ sub> and its preparation method
07/30/2014CN102272145B 亲和色谱基质 Affinity chromatography matrix
07/30/2014CN102209727B 抗TGF-β受体II抗体 Anti-TGF-β receptor II antibody
07/30/2014CN102170906B 靶定补体蛋白c5的抗体的组合物和方法 Compositions and methods of targeting antibodies to complement proteins c5
07/30/2014CN101885770B 一种特异性结合cd15的全人源抗体及应用 One kind of specific binding cd15 fully human antibodies and application
07/30/2014CN101855242B 合理设计的合成抗体文库及其用途 Rational design of synthetic antibody libraries and their uses
07/30/2014CN101516394B 制备抗耐药性抗原的活性抗体的方法、所述方法获得的抗体及其用途 Preparation of anti-resistance activity of the antigen antibody, an antibody obtained by said method and uses thereof
07/30/2014CN101432305B 运铁蛋白受体抗体 Transferrin receptor antibody
07/29/2014US8791323 Hybrid antibodies comprising human variable regions and mouse constant regions produced in a genetically modified mouse
07/29/2014US8791258 Pro-fluorescent probes
07/29/2014US8791244 Anti-ErbB3 antibodies and uses thereof
07/29/2014US8791243 Treatment and prophylaxis of amyloidosis
07/29/2014US8791242 Canine thymic stromal lymphopoietin protein and uses thereof to treat allergic symptoms
07/29/2014US8791068 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
07/29/2014US8791062 Skin permeating and cell entering (SPACE) peptides and methods of use thereof
07/29/2014US8790653 Peptide inhibitors for mediating stress responses
07/29/2014US8790652 Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis
07/29/2014US8790651 Interleukin-31 monoclonal antibody
07/29/2014US8790650 Methods of using an antibody to inhibit WNT-mediated cardiac remodeling
07/29/2014US8790649 EGFR-binding molecules and immunoconjugates thereof
07/29/2014US8790648 Methods of treating psoriasis using IL-17 receptor A antibodies
07/29/2014US8790646 Compositions and methods for modulating vascular development
07/29/2014US8790645 Pharmaceutical composition comprising a bispecific antibody for EpCAM
07/29/2014US8790644 Humanized antibodies that recognize alpha-synuclein
07/29/2014CA2718812C Porcine adenovirus type 3 genome
07/29/2014CA2691159C Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof
07/29/2014CA2592249C Binding proteins specific for human matriptase
07/29/2014CA2589487C Means and methods for detecting methylated dna
07/29/2014CA2537161C Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris)
07/29/2014CA2494974C Il-7 drug substance, composition, preparation and uses
07/29/2014CA2455365C Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
07/24/2014WO2014113712A1 Evaluation and treatment of bradykinin-mediated disorders
07/24/2014WO2014113510A1 Rapid clearance of antigen complexes using novel antibodies
07/24/2014WO2014113436A1 Adenoviruses and their use
07/24/2014WO2014111704A1 Antibodies that bind to jagged 1
07/24/2014WO2014111550A1 Modified anti-serum albumin binding proteins
07/24/2014WO2014111516A1 Mdr e. coli specific antibody
07/24/2014WO2014110675A1 Novel cell wall deconstruction enzymes of amorphotheca resinae, rhizomucor pusillus, and calcarisporiella thermophila, and uses thereof
07/24/2014WO2014110628A1 Gene and mutations thereof associated with seizure disorders
07/24/2014WO2014080015A3 Hair growth compositions and methods
07/24/2014WO2014074835A3 Antibody compositions and immunoassay methods to detect isoforms of anti-mullerian hormone
07/24/2014WO2014062659A3 Methods of treating ocular diseases
07/24/2014WO2013134743A9 Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof
07/24/2014US20140208455 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof
07/24/2014US20140206860 Nanoparticle chains and Preparation Thereof
07/24/2014US20140206853 Targeted binding agents directed to dll4 and uses thereof
07/24/2014US20140206849 Antibodies having reduced immunogenicity in a human
07/24/2014US20140206848 Oligosaccharide modification and labeling of proteins
07/24/2014US20140206847 Mutant protein capable of binding specifically and quickly to troponin i derived from human myocardium
07/24/2014US20140206846 Dual Targeting
07/24/2014US20140206845 Stable Protein-Containing Preparation Containing Argininamide or Analogous Compound Thereof
07/24/2014US20140206579 Dna libraries encoding frameworks with synthetic cdr regions
07/24/2014US20140206575 Collection and Methods For Its Use
07/24/2014US20140206558 System for production of antibodies and their derivatives
07/24/2014US20140206556 Systems and Methods for Identifying Replikin Scaffolds and Uses of Said Replikin Scaffolds
07/24/2014US20140206102 Methods and materials for detecting c9orf72 hexanucleotide repeat expansion positive frontotemporal lobar degeneration or c9orf72 hexanucleotide repeat expansion positive amyotrophic lateral sclerosis
07/24/2014US20140206039 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
07/24/2014US20140206038 Cell culture improvements
07/24/2014US20140206023 Methods, Kits & Antibodies for Detecting Intact Fibroblast Growth Factor 21
07/24/2014US20140206021 Prion protein ligands and methods of use
07/24/2014US20140206018 Antibodies against fatty acid synthase
07/24/2014US20140205615 Human cytomegalovirus neutralizing antibodies and use thereof
07/24/2014US20140205614 Neutralizing antibodies to influenza viruses
07/24/2014US20140205612 Human immunodeficiency virus (hiv)-neutralizing antibodies
07/24/2014US20140205611 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
07/24/2014US20140205610 Anti-folr1 antibody
07/24/2014US20140205608 Use of c-Fms antagonists
07/24/2014US20140205607 Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing
07/24/2014US20140205606 Anti c-met antibodies
07/24/2014US20140205605 Optimized antibodies that target hm1.24
07/24/2014US20140205604 Antigen binding constructs
07/24/2014US20140205603 Siglec-15 antibodies in treating bone loss-related disease
07/24/2014US20140205602 Antagonist anti-cd40 monoclonal antibodies and methods for their use
07/24/2014US20140205601 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
07/24/2014US20140205599 Polypeptide that binds aberrant cells and induces apoptosis
07/24/2014US20140205598 Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation
07/24/2014US20140205597 Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
07/24/2014US20140205593 Monovalent antibody fragments useful as therapeutics
07/24/2014US20140205562 Il-1 binding proteins
07/24/2014US20140205560 Multimeric il-15 soluble fusion molecules and methods of making and using same
07/24/2014US20140205544 Cancer Treatment Comprising Therapeutics That Bind To Phosphatidylserine
07/23/2014EP2757376A1 Molecular marker for early indentification of pleural mesothelioma patients, and expression analysis method for same
07/23/2014EP2757153A1 Method for assessing myelodysplastic syndrome or myeloid tumor predisposition, polypeptide and antibody therefor, and candidate screening method for therapeutic drug or prophylactic drug therefor
07/23/2014EP2757111A1 Anti-human norovirus gii antibody
07/23/2014EP2756312A1 Calibration reagent and method
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 1494